Dr. Shareen Rosalee Rodriques, MD

Dr. Rodriques practices at Middlesex Hospital in Middletown, Connecticut, part of Middlesex Health System.

Dr. Rodriques' NPI, 1396092425, was assigned on August 8, 2012. Dr. Rodriques holds Connecticut license 52869.

Dr. Rodriques' primary practice is Middlesex Hospital, at 28 Crescent St, Middletown, CT 06457 in Middlesex County. The practice phone is (860) 344-6000.

Dr. Rodriques' primary practice is Middlesex Hospital in Middletown, Connecticut, part of Middlesex Health System. The medical group on file is Middlesex Health. Dmand AI also links Dr. Rodriques to 2 more medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Rodriques practices. Vendor and product names are available with a free account.

Internal medicine is Dr. Rodriques' primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Rodriques is licensed in Connecticut.

CMS data shows 617 Medicare services from Dr. Rodriques across 5 procedure codes in 2024, for 241 Medicare patients. Medicare paid $49,375 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 241 Medicare patients who saw Dr. Rodriques in 2024. The largest group is 75 to 84, with 84 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 42% are also on Medicaid. Their average risk score is 2.60, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Rodriques' median patient age at 75, with 56% women.

In 2024, Dr. Rodriques wrote 303 Medicare Part D claims for 114 patients. 82% of them were for generic drugs. CMS names the drug for 97 of them, across 6 drugs with 11 or more claims each, at $1,125 in total drug cost. In 2023, CMS named 78 claims across 5 drugs.

Dr. Rodriques accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 31 general payments to Dr. Rodriques from 13 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. GlaxoSmithKline, LLC. paid the most, $83.